Ashwagandha and Male Testosterone Levels
Ashwagandha supplementation does increase serum testosterone levels in men, with clinical trials demonstrating increases ranging from 22-33% in stressed populations and approximately 57 ng/dL overall in men (but not in women). 1, 2
Evidence Quality and Strength
The available evidence comes exclusively from research studies, as no clinical guidelines address ashwagandha supplementation—the provided ACP guidelines 3 only address pharmaceutical testosterone replacement therapy for age-related low testosterone, not herbal supplements.
The most recent and comprehensive evidence is a 2026 systematic review and meta-analysis 1 that pooled data from 23 randomized controlled trials involving 1,706 patients. This analysis found:
- Testosterone increased by 57.43 ng/dL in men (statistically significant)
- No testosterone increase in women (5.09 ng/dL, not significant)
- Sex-specific effect confirmed with significant gender differences
Clinical Trial Evidence
Strongest Supporting Studies
The 2024 Shoden trial 2 provides the most robust single-study evidence:
- 60 subjects with high stress and elevated cortisol (>25 mcg/dL)
- Testosterone increased 22% with 60mg dose and 33% with 120mg dose of ashwagandha extract (35% withanolide glycosides)
- Placebo group showed only 4% increase
- Highly significant difference (p < 0.0001)
- Concurrent 66-67% reduction in morning cortisol levels
The 2026 sexual health trial 4 in 76 healthy men aged 30-50 demonstrated:
- 300mg twice daily for 8 weeks
- 36% increase in ejaculate volume
- 38% improvement in total sperm count
- 87% increase in total sperm motility
- Significant improvements in sexual function measures
Mechanism of Action
The testosterone-boosting effect appears to operate through multiple pathways:
- HPA axis modulation: Ashwagandha significantly reduces cortisol (standardized mean difference = -1.18, p < 0.04) 1, which removes cortisol's suppressive effect on testosterone production
- Direct testicular support: Preclinical evidence suggests protection of Leydig cells and steroidogenic enzyme function 5
- Stress reduction: By lowering psychological stress, it may restore normal hypothalamic-pituitary-gonadal axis function 2
Dosing Considerations
Based on the evidence:
- Effective dose range: 60-300mg twice daily (120-600mg total daily)
- Withanolide content matters: Extracts standardized to 35% withanolide glycosides showed strongest effects 2
- Duration: Significant effects observed at 8-12 weeks
- Dose-response relationship: Higher withanolide content may produce greater effects 1
Critical Context and Limitations
Population-Specific Effects
The testosterone increase is sex-specific and context-dependent:
- Men with high stress/elevated cortisol show the largest gains 2
- Healthy men with normal baseline testosterone also benefit 4
- Women do not experience testosterone elevation 1, 6, which is clinically important for safety
- Most studies enrolled men under 40 years old 7, limiting generalizability to older populations
Evidence Gaps
- No long-term safety data beyond 12 weeks
- Heterogeneity in extract standardization across studies makes direct comparisons difficult
- Small sample sizes in individual trials (typically 50-76 participants)
- No head-to-head comparison with pharmaceutical testosterone therapy
- Unknown effects in men with organic hypogonadism (Klinefelter syndrome, pituitary disorders, etc.)
Clinical Application Algorithm
For men seeking testosterone optimization:
If high stress/anxiety with suspected elevated cortisol: Ashwagandha 60-120mg twice daily (35% withanolide extract) is strongly supported 2
If healthy men with sexual function concerns: Ashwagandha 300mg twice daily shows clear benefit for testosterone, sperm parameters, and sexual function 4
If age-related low testosterone with symptoms: Consider ashwagandha as adjunctive or alternative to pharmaceutical therapy, but recognize this is extrapolated evidence—trials primarily enrolled younger men 7
Reassess at 8-12 weeks: Measure testosterone levels and symptom improvement; discontinue if no benefit
Safety Profile
All reviewed trials reported no adverse events with ashwagandha supplementation 2, 4. However:
- Long-term cardiovascular and prostate safety unknown (unlike pharmaceutical testosterone where concerns exist 3)
- Not FDA-approved for testosterone deficiency
- Quality and standardization vary significantly between commercial products
- Should not replace evaluation for organic causes of hypogonadism
Comparison to Pharmaceutical Testosterone
The ACP guidelines 3 note that pharmaceutical testosterone therapy provides only small improvements in sexual function with low-certainty evidence and unknown long-term safety. Ashwagandha's 22-33% testosterone increase 2 and demonstrated improvements in sexual function 4 suggest comparable or potentially superior benefit-to-risk ratio for men without organic hypogonadism, though direct comparative trials are lacking.
The critical distinction: FDA-approved testosterone is indicated only for men with hypogonadism from known organic causes 3, while ashwagandha evidence primarily comes from men with stress-related or functional testosterone concerns.